Novartis is reimagining medicine to improve and extend people’s lives. As a leading global medicines company, we use innovative science and digital technologies to create transformative treatments in areas of great medical need. In our quest to find new medicines, we consistently rank among the world’s top companies investing in research and development. Novartis products reach nearly 1 billion people globally and we are finding innovative ways to expand access to our latest treatments.
About 125 000 people of more than 140 nationalities work at Novartis around the world, of which more than 2.500 in Belgium. In 2017, Novartis invested approximately USD 9.0 billion in R&D (research and development). We are passionate about what we do and the impact we have on patients and our society.
For more information, visit our website: www.novartis.be.